Enorama Pharma AB (ERMA) — Working Capital to Net Assets Ratio
Enorama Pharma AB (ERMA) has a Working Capital to Net Assets ratio of 101.1% as of December 2025. Working capital of Skr-23.72 Million (current assets of Skr8.00 Million minus current liabilities of Skr31.71 Million) is measured against net assets of Skr-23.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ERMA net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Enorama Pharma AB Working Capital to Net Assets (2014–2025)
This chart shows how Enorama Pharma AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 101.1%, reflecting working capital of Skr-23.72 Million against net assets of Skr-23.45 Million SEK. Check Enorama Pharma AB (ERMA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Enorama Pharma AB (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Enorama Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Enorama Pharma AB worth.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.1% | Skr-23.72 Million | Skr-23.45 Million | Skr8.00 Million | Skr31.71 Million | ▲ +10.5 pp |
| 2024 | 90.6% | Skr7.07 Million | Skr7.80 Million | Skr15.16 Million | Skr8.09 Million | ▲ +76.5 pp |
| 2023 | 14.1% | Skr2.75 Million | Skr19.54 Million | Skr12.96 Million | Skr10.22 Million | ▲ +16.2 pp |
| 2022 | -2.1% | Skr-674.00K | Skr31.52 Million | Skr11.75 Million | Skr12.43 Million | ▼ -52.4 pp |
| 2021 | 50.3% | Skr10.73 Million | Skr21.35 Million | Skr22.41 Million | Skr11.68 Million | ▲ +376.0 pp |
| 2020 | -325.8% | Skr-5.79 Million | Skr1.78 Million | Skr12.82 Million | Skr18.61 Million | ▼ -431.8 pp |
| 2019 | 106.0% | Skr7.61 Million | Skr7.18 Million | Skr18.02 Million | Skr10.40 Million | ▲ +85.0 pp |
| 2018 | 21.0% | Skr3.57 Million | Skr17.02 Million | Skr18.28 Million | Skr14.71 Million | ▲ +61.4 pp |
| 2017 | -40.4% | Skr-2.98 Million | Skr7.36 Million | Skr2.10 Million | Skr5.08 Million | ▼ -71.6 pp |
| 2016 | 31.1% | Skr2.83 Million | Skr9.08 Million | Skr3.97 Million | Skr1.15 Million | ▲ +46.5 pp |
| 2015 | -15.4% | Skr-1.00 Million | Skr6.52 Million | Skr1.09 Million | Skr2.09 Million | ▲ +5.6 pp |
| 2014 | -21.0% | Skr-558.00K | Skr2.66 Million | Skr26.00K | Skr584.00K | — |